GSHD

Over the past six months, Goosehead Insurance's stock price has experienced a notable decline. As of October 8, 2026, the stock traded at $45.38, representing a decrease of 33.9% over the past year and 38.4% year-to-date. The stock price as of September 28, 2026, was $44.39, a decline of 39.61% from September 29, 2025. In the past month leading up to October 8, 2026, the stock decreased by 29.85%. Recent events impacting the stock include: Goosehead Insurance reported stronger Q2 2026 revenue and profitability, exceeding adjusted EPS and total revenue expectations, and raised the lower end of its full-year revenue outlook while announcing a planned CEO transition. On October 6, 2026, Piper Sandler downgraded Goosehead Insurance to Neutral from Overweight and lowered its price target to $48.00 from $72.00, citing concerns about growth acceleration. On October 1, 2026, JPMorgan Chase & Co. cut its price target from $68.00 to $60.00 and set a "neutral" rating. On September 29, 2026, Texas Capital Securities upgraded Goosehead Insurance to a Buy rating from Hold, setting a price target of $66, despite earlier concerns about AI disruption risks. On July 27, 2026, UBS Group raised its price target from $70.00 to $72.00 and maintained a "buy" rating. On July 23, 2026, Royal Bank of Canada lifted its price objective from $55.00 to $58.00 and gave a "sector perform" rating. Over the past 12 months, insider activity has shown net selling of $14.2 million, with insiders purchasing $20.1 million worth of shares while selling $34.3 million.